Group One Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Group One Trading’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.3K	Buy	+8,197	New	+$21.6K	﹤0.01%	6166
2026 Q1	–	Sell	-3,880	Closed	-$9.53K	–	8348
2025 Q4	$7.57K	Buy	+3,880	New	+$6.36K	﹤0.01%	6970
2023 Q2	–	Sell	-149,748	Closed	-$431K	–	8008
2023 Q1	$415K	Buy	149,748 +149,195	+26,979%	+$313K	﹤0.01%	2941
2022 Q4	$995	Sell	553 -2	-0.4%	-$4	﹤0.01%	6832
2022 Q3	$1K	Buy	+555	New	+$1.4K	﹤0.01%	7348
2021 Q4	–	Sell	-20,252	Closed	-$108K	–	8627
2021 Q3	$124K	Buy	+20,252	New	+$161K	﹤0.01%	5691

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Group One Trading's NAUT Position: Q2 2026 in Review

Group One Trading opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 8,197 shares worth $15.3K. The stake represents ﹤0.01% of the portfolio and ranks #6166 among its holdings. This is a return to the name: Group One Trading previously reported a position in NAUT as recently as Q4 2025.

Group One Trading first reported a position in NAUT in Q3 2021 and has held it in 6 quarters since. The position peaked at $415K in Q1 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Group One Trading held 8,197 shares of Nautilus Biotechnolgy worth $15.3K as of Q2 2026.
Nautilus Biotechnolgy was a new Group One Trading position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6166 holding.
Group One Trading first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 6 quarters since.
Group One Trading's Nautilus Biotechnolgy position peaked at $415K in Q1 2023.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.